CRP and metabolic syndrome: Hence, more prospective studies emphasizing the Framingham score change and C-reactive protein with patient follow-up are required to provide more detailed information on BBR’s efficacy in treating dyslipidemia, atherosclerosis, and overall cardiovascular benefit in the long run.